PaySign Inc Class B ( (PAYS) ) has released its Q3 earnings. Here is a breakdown of the information PaySign Inc Class B presented to its investors.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Paysign, Inc. is a financial services company specializing in prepaid card programs, pharma patient affordability, digital banking services, and integrated payment processing, primarily serving the healthcare industry. In its third quarter of 2025, Paysign reported record revenue of $21.6 million, marking a 41.6% increase from the previous year, alongside a net income rise of 54.2% to $2.22 million. The company’s Adjusted EBITDA also saw a substantial increase of 78.1% to $5.04 million, driven by significant growth in its pharma patient affordability and plasma revenue streams. Key highlights include a 141.9% increase in pharma patient affordability revenue and a 12.4% rise in plasma revenue, with the company expanding its active programs and plasma centers significantly over the past year. Paysign’s strategic expansion, including a new customer service contact center, positions it to meet growing demand and enhance service delivery. Looking forward, Paysign’s management remains optimistic about continued growth, particularly in the pharma patient affordability sector, as they anticipate further program additions and infrastructure enhancements to capitalize on emerging opportunities.